← Back to Search

Stigma-Reduction Training for Opioid Use Disorder

N/A
Recruiting
Led By Berkeley Franz, Ph.D.
Research Sponsored by Ohio University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months

Summary

This trial tests a training intervention to increase rural primary care providers' willingness to prescribe buprenorphine, a medication for opioid use disorder that may reduce HIV transmission.

Who is the study for?
This trial is for rural healthcare professionals who can legally prescribe buprenorphine, are at least 18 years old, and work in primary care as physicians, nurse practitioners, or physician assistants. It's not for those already prescribing buprenorphine to the maximum number of patients.
What is being tested?
The study is testing a stigma-reduction training program designed to encourage more rural health care providers to prescribe buprenorphine for opioid use disorder. The goal is to see if this training can change attitudes and increase prescription rates.
What are the potential side effects?
Since the intervention involves educational training rather than medication, there are no direct medical side effects. However, participants may experience changes in beliefs or attitudes about drug use and prescribing practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Adoption
Appropriateness
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: InterventionActive Control1 Intervention
Group II: ControlPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Ohio UniversityLead Sponsor
71 Previous Clinical Trials
17,311 Total Patients Enrolled
Ohio State UniversityOTHER
871 Previous Clinical Trials
655,332 Total Patients Enrolled
Rutgers UniversityOTHER
121 Previous Clinical Trials
2,808,954 Total Patients Enrolled
University of North CarolinaOTHER
170 Previous Clinical Trials
1,455,064 Total Patients Enrolled
Berkeley Franz, Ph.D.Principal InvestigatorOhio University Heritage College of Osteopathic Medicine

Media Library

Rural Health Services Clinical Trial 2023: Stigma-reduction training Highlights & Side Effects. Trial Name: NCT05505227 — N/A
~0 spots leftby Dec 2024